Patent · US Active

Delta-like ligand 1 for diagnosing severe infections

US11181532B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

Universität Heidelberg · DE

Inventors

Dagmar Hildebrand · Dossenheim, DE
Klaus Heeg · Marburg, DE
Florian Uhle · Heidelberg, DE
Markus Alexander Weigand · Wettenberg, DE

Key dates

Filing date	Oct 25, 2018
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Oct 25, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/26
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention refers to a method for in vitro diagnosis of a severe infection comprising determining delta-like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein in a biological sample wherein an elevated level of expression of delta-like ligand 1 protein or a nucleotide sequence coding for delta-like ligand 1 protein is indicative of a severe infection; and the use of delta-like ligand 1 protein as a biomarker for in vitro diagnosis of a severe infection such as sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.